Kala-Azar Comes to New York
- 28 April 1997
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 157 (8) , 921-923
- https://doi.org/10.1001/archinte.1997.00440290107012
Abstract
Visceral leishmaniasis (kala-azar) is a disseminated protozoal infection that occurs in areas of the world other than North America. In endemic regions, kala-azar is also an opportunistic infection associated with the acquired immunodeficiency syndrome. We report a case of acquired immunodeficiency syndrome—associated kala-azar acquired abroad that was first expressed in New York City. Human immunodeficiency virus—infected patients who have lived or traveled abroad may present in this country with unusual infections. Arch Intern Med. 1997;157:921-923This publication has 5 references indexed in Scilit:
- Treatment of kala-azar with oral fluconazoleThe Lancet, 1996
- Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patientsThe American Journal of Medicine, 1996
- Models of Relapse of Experimental Visceral LeishmaniasisThe Journal of Infectious Diseases, 1996
- Successful Treatment of Antimony-Resistant Visceral Leishmaniasis with Liposomal Amphotericin B in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1993
- Acquired Immunodeficiency Syndrome-Related Visceral Leishmaniasis Presenting in a Pleural EffusionChest, 1993